{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:19:27Z","timestamp":1785280767491,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11064-020-03054-7","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T07:04:07Z","timestamp":1589353447000},"page":"1913-1919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Diclofenac Versus Meloxicam in Pentylenetetrazol-Kindled Mice"],"prefix":"10.1007","volume":"45","author":[{"given":"Reham","family":"Elgarhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Abdelsameea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal E.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"issue":"6","key":"3054_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5698\/1535-7511-12.6.245","volume":"12","author":"MJ England","year":"2012","unstructured":"England MJ, Liverman CT, Schultz AM, Strawbridge LM (2012) A reprint from epilepsy across the spectrum: promoting health and understanding. Epilepsy Curr 12(6):245\u2013253","journal-title":"Epilepsy Curr"},{"issue":"1","key":"3054_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2016.47","volume":"29","author":"FM AlyuDikmen","year":"2017","unstructured":"AlyuDikmen FM (2017) Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr 29(1):1\u201316","journal-title":"Acta Neuropsychiatr"},{"key":"3054_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","volume":"69","author":"A Vezzani","year":"2013","unstructured":"Vezzani A, Friedman A, Dingledine RJ (2013) The role of inflammation in epileptogenesis. Neuropharmacol 69:16\u201324","journal-title":"Neuropharmacol"},{"issue":"7","key":"3054_CR4","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bbi.2011.03.018","volume":"25","author":"A Vezzani","year":"2011","unstructured":"Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T (2011) IL-1 receptor\/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25(7):1281\u20131289","journal-title":"Brain Behav Immun"},{"key":"3054_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-94-017-8914-1_14","volume":"813","author":"KS Wilcox","year":"2014","unstructured":"Wilcox KS, Vezzani A (2014) Does brain inflammation mediate pathological outcomes in epilepsy? Adv Exp Med Biol 813:169\u2013183","journal-title":"Adv Exp Med Biol"},{"key":"3054_CR6","doi-asserted-by":"crossref","unstructured":"Shimada T, Yamagata K. (2018). Pentylenetetrazole-induced kindling mouse model. J Vis Exp, 136.","DOI":"10.3791\/56573"},{"issue":"7","key":"3054_CR7","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/ph3072090","volume":"3","author":"A Wahab","year":"2010","unstructured":"Wahab A (2010) Difficulties in treatment and management of epilepsy and challenges in new drug development. Pharmaceuticals 3(7):2090\u20132110","journal-title":"Pharmaceuticals"},{"issue":"8","key":"3054_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40265-015-0392-z","volume":"75","author":"R Altman","year":"2015","unstructured":"Altman R, Bosch B, Brune K, Patrignani P, Young C (2015) Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs 75(8):859\u2013877","journal-title":"Drugs"},{"issue":"3","key":"3054_CR9","first-page":"1161","volume":"292","author":"I Tegeder","year":"2000","unstructured":"Tegeder I, Neupert W, Guhring H, Geisslinger G (2000) Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. J pharmacol Exp Ther 292(3):1161\u20131168","journal-title":"J pharmacol Exp Ther"},{"key":"3054_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.eplepsyres.2016.08.020","volume":"127","author":"V Vieiraa","year":"2016","unstructured":"Vieiraa V, Glassmannb D, Marafonb P, Pereirac P, Gomezc R, Coitinho AS (2016) Effect of diclofenac sodium on seizures and inflammatory profile induced by kindling seizure model. Epilepsy Res 127:107\u2013113","journal-title":"Epilepsy Res"},{"key":"3054_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/mol.104.007112","volume":"67","author":"A Peretz","year":"2005","unstructured":"Peretz A, Degani N, Nachman R (2005) Meclofenamic acid and diclofenac, novel templates of KCNQ2\/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol 67:1053\u20131066","journal-title":"Mol Pharmacol"},{"issue":"2","key":"3054_CR12","doi-asserted-by":"publisher","first-page":"e36412","DOI":"10.5812\/jjnpp.36412","volume":"12","author":"H Darvishi","year":"2016","unstructured":"Darvishi H, Rezaei M, Khodayar MJ, Zargar HR, Dehghani MA, Vardanjani HR, Ghanbari S (2016) Differential effects of meloxicam on pentylenetetrazole- and maximal electroshock-induced convulsions in mice. Jundishapur J Nat Pharm Prod 12(2):e36412","journal-title":"Jundishapur J Nat Pharm Prod"},{"issue":"6","key":"3054_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1179\/016164109X12464612122731","volume":"32","author":"T Hakan","year":"2010","unstructured":"Hakan T, Toklu HZ, Biber N, Ozevren H, Solakoglu S, Demirturk P, Aker FV (2010) Effect of COX-2 inhibitor meloxicam against traumatic brain. Neurol Res 32(6):629\u2013635","journal-title":"Neurol Res"},{"issue":"1","key":"3054_CR14","first-page":"6","volume":"21","author":"OE Erkec","year":"2015","unstructured":"Erkec OE, Arihan O (2015) Pentylenetetrazole kindling epilepsy model. Epilepsy 21(1):6\u201312","journal-title":"Epilepsy"},{"key":"3054_CR15","first-page":"6","volume":"21","author":"ZY Abdel-kader","year":"2015","unstructured":"Abdel-kader ZY, Khorshid NEA, Abd El motteleb D, Elwany NE (2015) Protective effect of montelukast against pentylenetetrazole induced acute seizures and kindling in mice. ZUMJ 21:6","journal-title":"ZUMJ"},{"issue":"1","key":"3054_CR16","first-page":"4","volume":"1","author":"HG Almaghour","year":"2014","unstructured":"Almaghour HG, Zawawi NM, Sherif FM (2014) Effect of non-steroidal anti-inflammatory drugs on anticonvulsant activity of diazepam in mice. Pharm pharmacol Int J 1(1):4","journal-title":"Pharm pharmacol Int J"},{"issue":"1","key":"3054_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eplepsyres.2007.10.008","volume":"78","author":"KK Akula","year":"2008","unstructured":"Akula KK, Dhir A, Kulkarni SK (2008) Rofecoxib, a selective cyclooxygenase-2 (COX- 2) inhibitor increase pentylenetetrazole seizure threshold in mice: possible involvement of adenosoinergic mechanism. Epilepsy Res 78(1):60\u201370","journal-title":"Epilepsy Res"},{"key":"3054_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"NM Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw NM, Ahmad N (2008) Dose translation from animal to human study should be revisited. FASEB J 22:659\u2013666","journal-title":"FASEB J"},{"key":"3054_CR19","doi-asserted-by":"crossref","unstructured":"Crowther J R. (2009). Stages in ELISA. Methods Mol Bio, 516\u201378.","DOI":"10.1007\/978-1-60327-254-4_3"},{"issue":"4","key":"3054_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00210-011-0606-1","volume":"383","author":"S Jain","year":"2011","unstructured":"Jain S, Bharal N, Khurana S, Mediratta PK, Sharma KK (2011) Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice. Naunyn Schmiedebergs Arch Pharmacol 383(4):385\u2013392","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3054_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0022-1759(92)90061-W","volume":"150","author":"T Prostmann","year":"1992","unstructured":"Prostmann T, Kiessing ST (1992) Enzyme immunoassay techniques. An overview. J Immunol Methods 150:5\u201321","journal-title":"J Immunol Methods"},{"issue":"2","key":"3054_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuint.2011.03.025","volume":"59","author":"EJ Shin","year":"2011","unstructured":"Shin EJ, Jeong JH, Chung YH, Kim WK, Ko KH, Bach JH (2011) Role of oxidative stress in epileptic seizures. Neurochem Int 59(2):122\u2013137","journal-title":"Neurochem Int"},{"issue":"1","key":"3054_CR23","first-page":"49","volume":"10","author":"AJ Reddy","year":"2018","unstructured":"Reddy AJ, Dubey AK, Handu SS, Sharma P, Mediratta PK, Ahmed QM, Jain S (2018) Anticonvulsant and antioxidant effects of musa sapientum stem extract on acute and chronic experimental models of epilepsy. Pharmacognosy Res 10(1):49\u201354","journal-title":"Pharmacognosy Res"},{"issue":"3","key":"3054_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0306-4522(96)00153-4","volume":"74","author":"AN Van Den Pol","year":"1996","unstructured":"Van Den Pol AN, Obrientan K, Belousov A (1996) Glutamate hyperexitability and seizure-like activity throughout the brain and spinal cord upon relief from chronic glutamate receptor blockade in culture. Neuroscience 74(3):653\u2013674","journal-title":"Neuroscience"},{"issue":"6","key":"3054_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1570159X12666140923205715","volume":"12","author":"B Martinc","year":"2014","unstructured":"Martinc B, Grabnar I, Vovk T (2014) Antioxidants as a preventive treatment for epileptic process: a review of the current status. Curr Neuropharmacol 12(6):527\u2013550","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"3054_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/jnc.12784","volume":"130","author":"CD G\u00f3mez","year":"2014","unstructured":"G\u00f3mez CD, Buijs RM, Sitges M (2014) The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1\u03b2 and TNF-\u03b1 expression in rat hippocampus. J Neurochem 130(6):770\u2013779","journal-title":"J Neurochem"},{"key":"3054_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","volume":"277","author":"QF Lenz","year":"2014","unstructured":"Lenz QF, Arroyo DS, Temp FR, Poersch AB, Masson CJ, Jesse AC (2014) Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood\u2013brain barrier dysfunction. Neuroscience 277:859\u2013871","journal-title":"Neuroscience"},{"key":"3054_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","volume":"8","author":"M Maroso","year":"2011","unstructured":"Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J (2011) Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8:304\u2013315","journal-title":"Neurotherapeutics"},{"issue":"11","key":"3054_CR29","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","volume":"46","author":"A Vezzani","year":"2005","unstructured":"Vezzani A, Granata T (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46(11):1724\u20131743","journal-title":"Epilepsia"},{"key":"3054_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"A Vezzani","year":"2013","unstructured":"Vezzani A, Aronica E, Mazarati A, Pittman QJ (2013) Epilepsy and brain inflammation. Exp Neurol 244:11\u201321","journal-title":"Exp Neurol"},{"key":"3054_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.expneurol.2013.05.010","volume":"247","author":"S Balosso","year":"2013","unstructured":"Balosso S, Ravizza T, Aronica E, Vezzani A (2013) The dual role of TNF-\u03b1 and its receptors in seizures. Exp Neurol 247:267\u2013271","journal-title":"Exp Neurol"},{"key":"3054_CR32","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/glia.22828","volume":"63","author":"Y He","year":"2015","unstructured":"He Y, Jackman NA, Thorn TL, Vought VE, Hewett SJ (2015) Interleukin-1\u03b2 protects astrocytes against oxidant-induced injury via an NF-\u0138B-development up regulation of glutathione synthesis. Glia 63:1568\u20131580","journal-title":"Glia"},{"key":"3054_CR33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","volume":"22","author":"A Vezzani","year":"2008","unstructured":"Vezzani A, Balosso S, Ravizza T (2008) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22:797\u2013803","journal-title":"Brain Behav Immun"},{"issue":"1\u20133","key":"3054_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2013.03.020","volume":"707","author":"S Suda","year":"2013","unstructured":"Suda S, Katsura K, Kanamaru T, Saito M, Katayama Y (2013) Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation. Eur J Pharmacol 707(1\u20133):26\u201331","journal-title":"Eur J Pharmacol"},{"key":"3054_CR35","unstructured":"Ximenes JC, Verde EC, Naffah-Mazzacoratti M, Viana GS. (2012). Valproic acid, a drug with multiple molecular targets related to its potential neuroprotective action. Neurosci & Med, 3\u00a0(1): Article ID:17746, 14 pages."},{"key":"3054_CR36","doi-asserted-by":"crossref","unstructured":"Himmerich H, Bartsch S, Hamer H, Mergl R, Sch\u00f6nherr J, Petersein C. (2014). Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-d40-stimulated blood in vitro. Oxid Med Cell Longev, 806162.","DOI":"10.1155\/2014\/806162"},{"issue":"10","key":"3054_CR37","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/glia.20830","volume":"57","author":"JA Black","year":"2009","unstructured":"Black JA, Liu S, Waxman SG (2009) Sodium channel activity modulates multiple functions in microglia. Glia 57(10):1072\u20131081","journal-title":"Glia"},{"key":"3054_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11131\/2018\/101384","volume":"8","author":"MI Khattab","year":"2018","unstructured":"Khattab MI, Kamel EM, Abbas NAT, Kaoud A (2018) Diclofenac influence on the anticonvulsant effect of retigabine: the potential role of KCNQ channels. Egyptian J Basic Clin Pharmacol 8:1\u201317","journal-title":"Egyptian J Basic Clin Pharmacol"},{"issue":"11","key":"3054_CR39","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1631\/jzus.B0820018","volume":"9","author":"HJ Zhang","year":"2008","unstructured":"Zhang HJ, Sun RP, Lei GF, Yang L, Liu CX (2008) Cyclooxygenase-2 inhibitor inhibits hippocampal synaptic reorganization in pilocarpine-induced status epilepticus rats. J Zhejiang Univ Sci B 9(11):903\u2013915","journal-title":"J Zhejiang Univ Sci B"},{"issue":"2","key":"3054_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10787-007-7007-6","volume":"16","author":"A Dhir","year":"2008","unstructured":"Dhir A, Akula KK, Kulkarni SK (2008) Rofecoxib potentiates the anticonvulsant effect of topiramate. Inflammopharmacology 16(2):83\u201386","journal-title":"Inflammopharmacology"},{"issue":"2","key":"3054_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00044-008-9109-0","volume":"18","author":"Z Haiju","year":"2008","unstructured":"Haiju Z, Ruopeng S, Gefei L, Lu Y, Chunxi L (2008) Cyclooxygenase-2 inhibitor inhibits the hippocampal synaptic reorganization by inhibiting MAPK\/ERK activity and modulating GABAergic transmission in pilocarpine-induced status epilepticus rats. Med Chem Res 18(2):71\u201390","journal-title":"Med Chem Res"},{"issue":"1","key":"3054_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.eplepsyres.2007.12.008","volume":"79","author":"MS Oliveira","year":"2008","unstructured":"Oliveira MS, Furian AF, Royes LF, Fighera MR, Fiorenza NG, Castelli M, Machado P, Bohrer D, Veiga M, Ferreira J, Cavalheiro EA, Mello CF (2008) Cyclooxygenase-2\/PGE2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res 79(1):14\u201321","journal-title":"Epilepsy Res"},{"issue":"1","key":"3054_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.eplepsyres.2008.12.006","volume":"84","author":"L Holtman","year":"2009","unstructured":"Holtman L, van Vliet EA, van Schaik R, Queiroz CM, Aronica E, Gorter JA (2009) Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res 84(1):56\u201366","journal-title":"Epilepsy Res"},{"key":"3054_CR44","doi-asserted-by":"crossref","unstructured":"Patsalos PN. (2010). Drug to Drug Interactions of Antiepileptic Drugs: Mechanisms of Interaction and Management Strategies. In: Panayiotopoulos C.P. (Eds) Atlas of Epilepsies. Springer, London.","DOI":"10.1007\/978-1-84882-128-6_217"},{"issue":"1","key":"3054_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/004982598239704","volume":"128","author":"C Chesn\u00e9","year":"1998","unstructured":"Chesn\u00e9 C, Guyomard C, Guillouzo A, Schmid J, Ludwig E, Sauter T (1998) Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4. Xenobiotica 128(1):1\u201313","journal-title":"Xenobiotica"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-020-03054-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T23:49:42Z","timestamp":1620863382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-020-03054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03054-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"28 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}